Funding Opportunities

Developmental Research Project and Career Enhancement Award Winners

2024 LMS SPORE Career Enhancement Program (CEP) Recipients:

Candace L. Haddox, M.D., Dana-Farber Cancer Institute
Project: Characterizing biologic mechanisms that determine whether leiomyosarcoma clinical course is indolent vs. typical

Erin E. Resch, M.D., Johns Hopkins University
Project: Combining chemotherapy with STING immunotherapy to improve treatment outcomes in osteosarcoma

2024 LMS SPORE Developmental Research Program (DRP) Recipients:

Emily Zhi-Yun Keung, M.D., A.M., F.A.C.S., MD Anderson Cancer Center
Project: Elucidation of Intratumoral Immune Microenvironment Characteristics of Primary Soft Tissue Sarcomas and Their Matched Regional and Distant Metastases

Marisa R. Nucci, M.D., Brigham & Women’s Hospital
Project: Deep Learning to Optimize Diagnosis & Therapeutic Selection for Uterine Leiomyosarcoma Patients

2023 LMS SPORE Career Enhancement Program (CEP) Recipient:

Josephine K. Dermawan, M.D., Ph.D., Cleveland Clinic
Project: Defining Novel Genomic Risk Stratification Models and Cellular Lineage in Leiomyosarcoma Subtypes

2023 LMS SPORE Developmental Research Program (DRP) Recipient:

Inga-Marie Schaefer, M.D., Brigham and Women’s Hospital
Project: Targeting cell cycle dysregulation in sarcomas with complex karyotypes

2022 LMS SPORE Career Enhancement Program (CEP) Recipient:

Elise F. Nassif, M.D., MD Anderson Cancer Center
Project: Identifying Biomarker-Based Immune Targets in Molecular Subtypes of Leiomyosarcomas

2022 LMS SPORE Developmental Research Program (DRP) Recipients:

Nicolas J. Llosa, M.D., Johns Hopkins Medicine
Project: Immunotherapeutic barriers at the level of the Leiomyosarcoma immune microenvironment

Brittany L. Siontis, M.D., Mayo Clinic
Project: Multi-Omics to Distinguish Leiomyosarcoma Subtypes